Post by dipikakapurdipa on Feb 18, 2024 5:19:20 GMT -5
President Donald Trump has been characterized by the large number of actions and comments he has made since his election campaign and during his government. Among his statements, he recently stated that he wants to accelerate the approval of an experimental vaccine against COVID-19 that is being developed in the United Kingdom for use in the United States before the presidential elections. In an attempt to secure a COVID-19 vaccine by Nov. 3, Trump is seeking emergency use authorization from the U.S. Food and Drug Administration for the vaccine being developed by the University of Oxford in the weeks before the election, even if it does not yet have full regulatory approval, the Financial Times reports , citing unnamed sources. Oxford's vaccine, which is being developed in partnership with pharmaceutical company AstraZeneca, will be tested on 10,000 volunteers in the coming weeks; However, US health authorities have indicated that a vaccine must be successfully tested in 30,000 volunteers to receive authorization. Two senior Trump administration officials told House Speaker Nancy Pelosi in a meeting last month that the president wanted to avoid these requirements by granting emergency use authorization for the vaccine, they told the Financial Times.
An anonymous source informed of the meeting. White House Chief of Staff Mark Meadows and Treasury Secretary Steven Mnuchin said they expected a vaccine to receive emergency use authorization before the election and possibly as early as next month. A Treasury representative denied that Mnuchin made any comments about AstraZeneca at that meeting, stating: He is also not aware of any plans the FDA may have regarding any emergency use authorization for any potential America Cell Phone Number List vaccine, beyond what he has heard stated publicly. Michael Caputo, a representative of the Department of Health and Human Services, denied that the FDA granted emergency use authorization for a vaccine before the election, calling the idea " absolutely false ." And he told the Financial Times that the stated goal of developing a vaccine by the first quarter of 2021 had not changed and that talk of one being available to the public in October was a " creepy Resistance fantasy ." Irresponsible talk of an unsafe or ineffective vaccine being approved for public use is designed to undermine the president's response to the coronavirus. Michael Caputo, representative of the Department of Health and Human Services.
At the same time, President Donald Trump has publicly expressed his desire to have a vaccine sooner. On Saturday, Trump accused the FDA (without evidence) of trying to delay a COVID-19 vaccine until after the election for political reasons. In addition to this, he published a tweet in which he tagged Dr. Stephen Hahn, commissioner of the FDA, where he said: The deep state, or whoever, at the FDA is making it very difficult for drug companies to get people to test vaccines and therapies. Obviously, they hope to delay the response until after November 3rd. You must focus on speed, and saving lives! Donald Trump, president of the United States. On Saturday, Pelosi said the president's tweet was " very dangerous " and that " even for him, it went beyond the pale in terms of how it would jeopardize the health and well-being of the American people ." The dangers of insufficient testing Oxford researchers are leading the race to produce a fully tested vaccine and have agreed with AstraZeneca to produce up to 2 billion doses. The team, led by Dr. Sarah Gilbert, began human testing of the vaccine in April, at which time she said it could be effective in September. For his part, Dr. Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, has urged caution about Oxford's leadership status, reflecting the fact that most vaccines do not get the regulatory approval. You have to be careful if you're temporarily leading the way, it doesn't necessarily translate into a vaccine that's actually going to work. Dr. Anthony Fauci, director of the United States National Institute of Allergy and Infectious Diseases.
An anonymous source informed of the meeting. White House Chief of Staff Mark Meadows and Treasury Secretary Steven Mnuchin said they expected a vaccine to receive emergency use authorization before the election and possibly as early as next month. A Treasury representative denied that Mnuchin made any comments about AstraZeneca at that meeting, stating: He is also not aware of any plans the FDA may have regarding any emergency use authorization for any potential America Cell Phone Number List vaccine, beyond what he has heard stated publicly. Michael Caputo, a representative of the Department of Health and Human Services, denied that the FDA granted emergency use authorization for a vaccine before the election, calling the idea " absolutely false ." And he told the Financial Times that the stated goal of developing a vaccine by the first quarter of 2021 had not changed and that talk of one being available to the public in October was a " creepy Resistance fantasy ." Irresponsible talk of an unsafe or ineffective vaccine being approved for public use is designed to undermine the president's response to the coronavirus. Michael Caputo, representative of the Department of Health and Human Services.
At the same time, President Donald Trump has publicly expressed his desire to have a vaccine sooner. On Saturday, Trump accused the FDA (without evidence) of trying to delay a COVID-19 vaccine until after the election for political reasons. In addition to this, he published a tweet in which he tagged Dr. Stephen Hahn, commissioner of the FDA, where he said: The deep state, or whoever, at the FDA is making it very difficult for drug companies to get people to test vaccines and therapies. Obviously, they hope to delay the response until after November 3rd. You must focus on speed, and saving lives! Donald Trump, president of the United States. On Saturday, Pelosi said the president's tweet was " very dangerous " and that " even for him, it went beyond the pale in terms of how it would jeopardize the health and well-being of the American people ." The dangers of insufficient testing Oxford researchers are leading the race to produce a fully tested vaccine and have agreed with AstraZeneca to produce up to 2 billion doses. The team, led by Dr. Sarah Gilbert, began human testing of the vaccine in April, at which time she said it could be effective in September. For his part, Dr. Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, has urged caution about Oxford's leadership status, reflecting the fact that most vaccines do not get the regulatory approval. You have to be careful if you're temporarily leading the way, it doesn't necessarily translate into a vaccine that's actually going to work. Dr. Anthony Fauci, director of the United States National Institute of Allergy and Infectious Diseases.